Testosterone in Metastatic Renal Cell Carcinoma Patients
Status:
Completed
Trial end date:
2019-07-30
Target enrollment:
Participant gender:
Summary
Purpose
To determine efficacy and safety of Testosterone in male patients with metastatic renal cell
carcinoma and fatigue receiving targeted therapy or checkpoint inhibitors.